iconstar paper   HIV Articles  
Back grey arrow rt.gif
 
 
GS-9883 (non-boosed integrase inhibitor),
F/TAF (emtricitabine/tenofovir alafenamide)
 
 
  Safety and Efficacy of GS-9883 + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults......https://clinicaltrials.gov/ct2/show/NCT02397694
 
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9883 + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org